Sanofi (NASDAQ:SNY) Shares Sold by Eagle Ridge Investment Management

Eagle Ridge Investment Management decreased its stake in Sanofi (NASDAQ:SNY) by 83.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,368 shares of the company’s stock after selling 26,977 shares during the period. Eagle Ridge Investment Management’s holdings in Sanofi were worth $261,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of SNY. Qube Research & Technologies Ltd acquired a new position in Sanofi in the 3rd quarter worth $3,945,000. Toronto Dominion Bank lifted its stake in shares of Sanofi by 175.4% in the third quarter. Toronto Dominion Bank now owns 2,294 shares of the company’s stock worth $123,000 after acquiring an additional 1,461 shares in the last quarter. Rehmann Capital Advisory Group boosted its holdings in Sanofi by 12.1% in the third quarter. Rehmann Capital Advisory Group now owns 11,793 shares of the company’s stock valued at $633,000 after purchasing an additional 1,275 shares during the last quarter. Logan Capital Management Inc. grew its stake in Sanofi by 5.7% during the 3rd quarter. Logan Capital Management Inc. now owns 68,903 shares of the company’s stock valued at $3,696,000 after purchasing an additional 3,739 shares in the last quarter. Finally, Insigneo Advisory Services LLC increased its holdings in Sanofi by 7.5% during the 3rd quarter. Insigneo Advisory Services LLC now owns 6,753 shares of the company’s stock worth $362,000 after purchasing an additional 474 shares during the last quarter. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Stock Down 2.1 %

Shares of SNY traded down $1.05 during trading on Tuesday, reaching $48.54. The company’s stock had a trading volume of 2,653,909 shares, compared to its average volume of 2,123,625. Sanofi has a twelve month low of $42.63 and a twelve month high of $55.72. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The company has a market cap of $122.94 billion, a price-to-earnings ratio of 24.39, a P/E/G ratio of 1.50 and a beta of 0.59. The company has a fifty day moving average of $48.68 and a two-hundred day moving average of $48.57.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.96. The firm had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. On average, sell-side analysts predict that Sanofi will post 4.13 EPS for the current fiscal year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.